Aortic Aneurysm — Clinical Documentation Guide (2026)

🔍 Definition

An aortic aneurysm is a permanent, pathological dilation of the aorta to at least 1.5 times its normal diameter — or, by the most widely applied clinical threshold, an absolute diameter ≥3.0 cm for the abdominal aorta and ≥4.0 cm for the thoracic aorta. Unlike pseudoaneurysms, which involve only the outer adventitial layer, true aneurysms involve all three layers of the arterial wall (intima, media, and adventitia). Aortic dissection (ICD-10-CM I71.0x) is a separate but related pathology in which a tear in the intimal layer allows blood to track within the medial plane, creating a false lumen — the distinction is critical for code assignment and DRG mapping. Per CMS FY2026 ICD-10-CM Official Guidelines Section I.C.9, coders must clearly distinguish rupture status, anatomic location, and dissection involvement when sequencing these codes.

Aortic aneurysms are broadly classified by location:

• Thoracic aortic aneurysm (TAA) — ascending aorta, aortic arch, or descending thoracic aorta (above the diaphragm)
• Abdominal aortic aneurysm (AAA) — infrarenal (most common, ~80%), juxtarenal, or suprarenal segments below the diaphragm
• Thoracoabdominal aortic aneurysm (TAAA) — spans both the thoracic and abdominal aorta (Crawford classification I–IV)

Size thresholds guide surgical decision-making per 2022 ACC/AHA Aorta Guidelines:

• <3.0 cm — Normal aortic diameter
• 3.0–3.9 cm — Aortic ectasia (not yet aneurysmal by strict definition)
• 4.0–4.9 cm — Small AAA (surveillance every 12 months)
• 5.0–5.4 cm — Moderate AAA (surveillance every 6 months)
• ≥5.5 cm in men / ≥5.0 cm in women — Large AAA; surgical/endovascular repair indicated
• TAA: repair recommended at ≥5.5 cm (ascending) or ≥5.5–6.0 cm (descending) by guidelines

🗂️ Alternative Terminology

The following table lists formal ICD-10-CM terminology alongside common clinical, colloquial, and lay terms coders and CDI specialists encounter in the medical record:

🩺 Signs & Symptoms

Most aortic aneurysms are asymptomatic and discovered incidentally on imaging performed for other reasons (e.g., abdominal ultrasound, CT scan). Symptomatic presentations indicate rapid expansion, impending rupture, or associated dissection and require urgent attention.

Abdominal Aortic Aneurysm (AAA)

• Asymptomatic: Pulsatile abdominal mass on exam (sensitivity varies by body habitus and aneurysm size)
• Symptomatic (expanding/leaking): Mid-abdominal or back pain, flank pain radiating to groin, new-onset hypotension
• Ruptured: Classic triad of hypotension, severe back/flank pain, and pulsatile abdominal mass; high mortality (>80% if not emergently repaired)

Thoracic Aortic Aneurysm (TAA)

• Asymptomatic: Most TAAs are found incidentally on chest X-ray or CT
• Symptomatic: Deep chest pain, back pain between scapulae, hoarseness (recurrent laryngeal nerve compression), dysphagia (esophageal compression), stridor (tracheal compression), superior vena cava syndrome
• Dissection (Type A): Sudden severe “tearing” or “ripping” chest pain radiating to the back; pulse differentials; stroke symptoms; aortic regurgitation murmur
• Dissection (Type B): Severe interscapular back pain; may have limb ischemia if branch vessels compromised

Ruptured Aneurysm (Any Site)

• Hemodynamic instability / shock
• Acute abdomen or chest
• Ecchymosis (Grey Turner sign for retroperitoneal bleed)
• Altered mental status from hypoperfusion

🧭 Differential Diagnosis

The differential for aortic aneurysm and dissection includes multiple vascular, musculoskeletal, and gastrointestinal conditions. Documentation specificity is essential for correct code assignment.

📋 Clinical Indicators for Coders/CDI

The following clinical indicators support documentation and coding specificity for aortic aneurysm. Coders and CDI specialists should confirm each element is clearly supported in the medical record before assigning codes.

🦴 Anatomy & Pathophysiology

The aorta is the largest artery in the body, originating at the aortic valve and coursing through the chest (thoracic aorta) and abdomen (abdominal aorta) before bifurcating into the iliac arteries at the level of L4. The wall consists of three layers: the inner tunica intima (endothelium), the medial tunica media (smooth muscle and elastic fibers), and the outer tunica adventitia (connective tissue). Aneurysm formation results from progressive degradation of the medial wall.

Pathogenic Mechanisms

• Atherosclerosis: The predominant mechanism in AAA. Chronic inflammation, macrophage infiltration, matrix metalloproteinase (MMP) release, and elastin/collagen degradation weaken the medial wall, producing infrarenal dilation. Risk factors: smoking (strongest independent risk factor), age >65, male sex, hypertension, hyperlipidemia.
• Medial degeneration (cystic medial necrosis): Primary mechanism in TAA. Smooth muscle cell apoptosis and extracellular matrix degeneration, accelerated by hypertension; hallmark of Marfan syndrome, Ehlers-Danlos syndrome, and bicuspid aortic valve disease.
• Genetic/heritable: FBN1 gene mutations (Marfan), COL3A1 (Ehlers-Danlos type IV, vascular), TGFBR1/2 (Loeys-Dietz), ACTA2 — all produce familial TAA syndromes. Family history of AAA increases risk 10-fold.
• Inflammatory/infectious: Mycotic aneurysms from septic emboli (Salmonella, Staphylococcus); Takayasu’s arteritis and giant cell arteritis can produce aneurysmal dilation.
• Post-traumatic: Traumatic pseudoaneurysm following blunt thoracic trauma (aortic isthmus most common site).

Dissection Pathophysiology

Aortic dissection begins with an intimal tear, most commonly in the proximal ascending aorta (2–3 cm above the aortic valve) or just distal to the left subclavian artery origin. Blood enters the media under systemic pressure, creating a false lumen that propagates distally (and sometimes proximally). The false lumen may compress the true lumen and branch vessel ostia, causing malperfusion of coronary arteries (Type A), cerebral vessels, mesenteric vessels, or renal arteries.

Per the 2022 ACC/AHA Aorta Guidelines, classification systems include:

• Stanford Classification: Type A — involves ascending aorta (surgical emergency); Type B — confined to descending aorta (typically medical management)
• DeBakey Classification: Type I — originates in ascending, extends to descending; Type II — confined to ascending; Type III — originates in descending (IIIa: above diaphragm, IIIb: extends below diaphragm)

💊 Medication Impact / Treatment

Pharmacologic management plays a central role in aortic aneurysm disease — both as primary treatment for smaller aneurysms and as peri-operative management for surgical candidates. Documentation of medications in the medical record supports CDI capture of comorbidities, complications, and treatment response.

Medical Management (Non-surgical)

• Beta-blockers (metoprolol, atenolol, bisoprolol): First-line therapy for thoracic aortic disease; reduce heart rate and aortic wall stress (dP/dt); especially important in Marfan and Loeys-Dietz syndromes per ACC/AHA guidelines. ICD-10-CM: Add Z79.899 (other long-term drug therapy) if appropriate.
• ARBs (losartan, valsartan): Evidence-based alternative in connective tissue disorders; reduce TGF-β signaling, slowing dilation rate in Marfan syndrome.
• Statins: Reduce perioperative cardiovascular risk; possible effect on aneurysm growth rate (unclear per current evidence). Document hyperlipidemia separately (E78.x).
• Antihypertensives: Blood pressure control (<130/80 mmHg) is mandatory; any class may be used. Uncontrolled hypertension (I10) accelerates aneurysm expansion and dissection risk.
• Anticoagulation / antiplatelet: Not routinely used for aneurysm alone; post-EVAR, antiplatelet agents (aspirin ± clopidogrel) are standard.

Medical Management of Acute Type B Dissection

• IV beta-blocker (esmolol, labetalol) to reduce systolic BP to 100–120 mmHg and heart rate <60 bpm
• Sodium nitroprusside (if beta-blocker inadequate) — adjunctive vasodilator
• Pain control (IV opioids), volume resuscitation as needed

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines (FY2026)

Aortic aneurysm and dissection coding is governed by CMS FY2026 ICD-10-CM Official Guidelines Section I.C.9 (Diseases of the Circulatory System). The following points are essential for accurate code assignment:

Key Guideline Principles

1. Rupture specificity is mandatory: The I71 category requires coders to identify whether the aneurysm is ruptured (I71.1, I71.3, I71.5, I71.8) or without rupture (I71.2, I71.4, I71.6, I71.9). “Rupture” must be explicitly documented by the treating physician — inferred from hemodynamic instability alone is insufficient per Official Guidelines Section II (query guidelines for uncertain diagnoses in inpatient settings).
2. Dissection is sequenced before aneurysm: When both dissection and aneurysm coexist in the same anatomic location and both are documented, assign the dissection code (I71.0x) as the principal diagnosis and the aneurysm code as an additional code if the aneurysm is separately documented as a distinct process.
3. Congenital vs. acquired: Congenital aortic aneurysm (Q25.43) is coded separately from acquired aneurysms (I71.x). Marfan syndrome (Q87.40) or Ehlers-Danlos (Q79.60) causing aortic dilation should be assigned as the underlying etiology with the I71.x code as an additional code per ICD-10-CM Etiology/Manifestation convention when applicable.
4. Atherosclerosis as additional code: I70.0 (Atherosclerosis of aorta) may be assigned with I71.x if atherosclerosis is independently documented. Per guidelines, atherosclerosis and aneurysm are not automatically linked — documentation of the relationship is required to sequence I70.0 as principal.
5. Prior repair complications: Post-EVAR/TEVAR endoleak is coded to T82.318A/T82.318D/T82.318S (Breakdown/Leakage of other vascular grafts) + I71.x for the underlying condition. Z98.85 (presence of other specified functional implants — vascular grafts) is assigned for surveillance visits after repair.
6. Screening encounters: Z13.6 (encounter for screening for cardiovascular disorders) is assigned as the principal diagnosis for one-time AAA screening ultrasound in appropriate patients (U.S. Preventive Services Task Force [USPSTF] recommends one-time screening for men 65–75 who have ever smoked). See USPSTF AAA Screening Recommendation.
7. Inpatient uncertain diagnoses: Per Official Guidelines Section II.H, for inpatient encounters, uncertain diagnoses (e.g., “probable dissection”) may be coded as confirmed. This differs from outpatient coding, where only confirmed diagnoses are coded.

MS-DRG Impact

Aortic aneurysm diagnoses map to several MS-DRG groups depending on the procedure performed and complication/comorbidity (CC/MCC) status under CMS MS-DRG v42 (FY2026):

• DRG 237/238/239 — Major Cardiovascular Procedures with MCC/CC/without CC (includes EVAR and open aortic repair)
• DRG 252/253/254 — Other Vascular Procedures with MCC/CC/without CC
• DRG 299/300/301 — Peripheral Vascular Disorders with MCC/CC/without CC (medical management of AAA without surgery)
• Ruptured aneurysm with hemorrhage qualifies as MCC, significantly elevating DRG weight and reimbursement

🔢 ICD-10-CM Code Set (FY2026)

All codes below are valid for FY2026 ICD-10-CM (effective October 1, 2025).

Primary Codes — Aortic Dissection (I71.0x)

Thoracic Aortic Aneurysm

Abdominal Aortic Aneurysm

Thoracoabdominal Aortic Aneurysm

Unspecified Site

Related / Etiology Codes

🔎 Indexing

Use the ICD-10-CM Alphabetic Index as the starting point for code assignment, then verify in the Tabular List. Key index pathways for aortic aneurysm:

🏥 CPT (2026)

All CPT codes below are from the AMA CPT 2026 Professional Edition. Aortic aneurysm procedures span vascular surgery (open repair) and interventional/endovascular approaches.

Open Surgical Repair

Endovascular Aortic Repair (EVAR) — Abdominal

Imaging / Supervision Codes

🧾 HCPCS (2026)

The following HCPCS Level II codes are commonly used in aortic aneurysm cases for device reporting, primarily in outpatient hospital, ASC, and inpatient facility billing contexts per CMS HCPCS 2026:

📚 AHA Coding Clinic (Recent Guidance)

The AHA Coding Clinic for ICD-10-CM/PCS is the official source of coding advice for ICD-10-CM. The following represent key guidance relevant to aortic aneurysm coding:

💰 HCC / Risk Adjustment (v28)

Under the CMS-HCC Model Version 28 (implemented for 2024 payment year, phased in through 2026), aortic aneurysm diagnoses map to HCC 267 (Vascular Disease). The HCC model is used for Medicare Advantage risk adjustment, ACO MSSP, and value-based care programs.

HCC Documentation Tips

• Aortic aneurysm must be documented as an active, current condition (not just history) to capture HCC 267 RAF credit for the payment year. “History of AAA — no current repair needed, under surveillance” with an active surveillance plan typically qualifies as an active condition per CMS chronic condition guidance.
• For Medicare Advantage annual wellness visits, ensure the treating physician documents the aneurysm with current size, management plan, and clinical status — not merely “history of.”
• Post-EVAR/TEVAR repair: The underlying aneurysm condition (I71.x) should still be coded to capture ongoing HCC RAF credit in years after repair, unless the physician documents the aneurysm as “resolved” — which is rare since aortic aneurysms persist anatomically even after endovascular repair. Z98.85 (graft presence) captures the repair history but does not contribute HCC points; the I71.x diagnosis does.
• Ruptured aneurysm (I71.1, I71.3, I71.5, I71.8) — code these only during the acute encounter. In subsequent years, use the non-ruptured code or status/history code as appropriate after repair.

✍️ CDI Query Templates

The following query templates are designed in compliance with AHIMA and ACDIS query practice standards — non-leading, evidence-based, multiple-choice format. Queries must be initiated when clinical indicators support a diagnosis not clearly documented.

🧑‍⚕️ Treatments (Clinical)

Treatment of aortic aneurysm is stratified by aneurysm size, location, rate of growth, symptoms, and patient operative risk per the 2022 ACC/AHA Aorta Guidelines.

Surveillance (Non-Operative Management)

• AAA 3.0–3.9 cm: Ultrasound every 3–5 years
• AAA 4.0–4.9 cm: Ultrasound every 12 months; CTA if rapid growth (>0.5 cm/6 months)
• AAA 5.0–5.4 cm: Ultrasound or CTA every 6 months; surgical consultation
• TAA: Annual CTA for diameters 4.0–5.0 cm; more frequent for growth rate >0.5 cm/year
• Risk factor modification: Smoking cessation (single most impactful intervention), blood pressure control, statin therapy, exercise guidance

Elective Open Surgical Repair (OSR)

• Infrarenal AAA: Transperitoneal or retroperitoneal approach; Dacron tube graft (aorto-aortic) or bifurcated graft (aorto-bifemoral/iliac)
• Suprarenal/juxtarenal AAA: Requires temporary renal ischemia or cold perfusion; higher mortality/morbidity
• TAAA: Crawford extent I–IV classification guides complexity; often requires spinal cord perfusion strategies (spinal drainage, staged repair) to prevent paraplegia
• Open OSR mortality (elective infrarenal): 1–4% at high-volume centers; 5–8% at lower-volume hospitals per ACC/AHA guidelines

Endovascular Aneurysm Repair (EVAR / TEVAR)

• EVAR (infrarenal AAA): Catheter-based delivery of bifurcated stent-graft via femoral arteriotomy/puncture; shorter hospital stay, reduced perioperative mortality vs. open repair; long-term durability concerns (endoleak, graft migration); requires lifelong imaging surveillance
• TEVAR (descending TAA): Stent-graft deployment via femoral or iliac access; left subclavian artery may require revascularization if landing zone inadequate; spinal cord ischemia risk (1–3%)
• Fenestrated EVAR (FEVAR): Custom-designed device with fenestrations or branches to preserve renal and visceral vessel flow; used for juxtarenal, pararenal, and TAAA; off-the-shelf devices in development
• Chimney/snorkel EVAR: Parallel stent-graft technique extending proximal landing zone; alternative when custom FEVAR not available
• Post-EVAR endoleak types: Type I (seal failure at attachment sites), Type II (retrograde branch flow), Type III (component separation), Type IV (graft porosity), Type V (endotension)

Emergency Repair — Ruptured AAA/TAA

• Immediate fluid resuscitation (permissive hypotension targeting SBP 50–70 mmHg until aortic control)
• EVAR preferred over open repair when anatomy permits and team/equipment available — improved 30-day mortality in EVAR-eligible patients
• Open repair for anatomically unsuitable EVAR or when endovascular team/OR not immediately available
• Aortic balloon occlusion (REBOA) as bridge to definitive repair in select centers

Aortic Dissection Treatment

• Type A dissection: Surgical emergency — emergency ascending aortic replacement ± aortic root replacement, coronary reimplantation if involved; overall mortality without surgery ~1–2% per hour in first 24–48 hours per ACC/AHA guidelines
• Type B dissection (uncomplicated): Medical management (IV beta-blockers, blood pressure control); 10-year survival ~60% with optimal medical therapy
• Type B dissection (complicated): TEVAR for malperfusion, refractory hypertension, rapid expansion, or impending rupture; PETTICOAT technique (provisional extension to induce complete attachment) in selected cases

🎓 Patient Education / Summary

The following section is intended to support clinical documentation specialists and coders in understanding what patients are typically told about their condition — context that aids in interpreting physician notes and identifying documentation gaps.

What Is an Aortic Aneurysm?

An aortic aneurysm is a bulge or widening in the wall of the aorta — the main artery that carries blood from the heart to the rest of the body. The aorta normally measures about 2 cm (roughly the width of a thumb) in the abdomen. An aneurysm develops when the wall weakens and stretches outward. Most aneurysms grow slowly and cause no symptoms until they become large or rupture.

Key Patient Education Points

• Smoking cessation is the single most important modifiable risk factor — patients who quit smoking reduce their aneurysm growth rate by approximately 20–30% per year per available evidence
• Blood pressure control is essential — high blood pressure puts additional stress on the weakened aortic wall
• Regular imaging surveillance is required — missing a scheduled ultrasound or CT can mean missing rapid growth before a rupture
• Warning signs of rupture or expansion: sudden severe abdominal or back pain, dizziness, or fainting — go to the emergency room immediately
• Genetic screening: Patients with Marfan syndrome, Ehlers-Danlos syndrome, or a family history of aortic aneurysm should inform their relatives, who may also need screening
• After EVAR/TEVAR: Lifelong follow-up imaging (typically annual CT) is required to detect endoleak, graft migration, or aneurysm sac growth

Screening Eligibility (USPSTF Recommendation)

Per the USPSTF Grade B recommendation, a one-time abdominal ultrasound screening for AAA (CPT 76706) is recommended for:

• Men aged 65–75 years
• Who have ever smoked (defined as ≥100 cigarettes in a lifetime)
• Medicare covers this as a preventive benefit (no cost-sharing) when ordered at the “Welcome to Medicare” preventive visit or as a standalone Medicare Part B preventive benefit for eligible beneficiaries

Women with a history of smoking or a family history of AAA may also benefit from screening, though the USPSTF recommendation is specifically for men. The 2022 ACC/AHA guidelines also recommend screening consideration for women 65–75 who have ever smoked (Class IIa recommendation).

Living with Aortic Aneurysm

Patients with a known aortic aneurysm under surveillance should be counseled to:

• Avoid heavy lifting or vigorous isometric exercise (Valsalva maneuver increases aortic wall tension) — guidelines recommend avoiding exertion that causes straining until cleared by their vascular surgeon
• Maintain a heart-healthy diet (Mediterranean pattern) to control blood pressure and cholesterol
• Take prescribed medications consistently — particularly beta-blockers and antihypertensives
• Wear a medical alert bracelet identifying the condition for emergency personnel
• Discuss driving restrictions and air travel with their physician if symptomatic or if rapid expansion has been documented

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)